Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 33.53 USD -1.87% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Immunocore Holdings PLC
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Immunocore Holdings PLC
Stock-Based Compensation Peer Comparison

Comparables:
CNTA
EXAI
AUTL
BCYC
GNS

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Immunocore Holdings PLC
NASDAQ:IMCR
Stock-Based Compensation
ÂŁ32.5m
CAGR 3-Years
58%
CAGR 5-Years
117%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Stock-Based Compensation
ÂŁ24.4m
CAGR 3-Years
127%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Stock-Based Compensation
$11.2m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Immunocore Holdings PLC's Stock-Based Compensation?
Stock-Based Compensation
32.5m GBP

Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Stock-Based Compensation amounts to 32.5m GBP.

What is Immunocore Holdings PLC's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
117%

Over the last year, the Stock-Based Compensation growth was -1%. The average annual Stock-Based Compensation growth rates for Immunocore Holdings PLC have been 58% over the past three years , 117% over the past five years .

Back to Top